by Bill Malloy | Aug 15, 2023 | Cancer, Health, Pharmaceuticals
A recent immunotherapy clinical trial by the Memorial Sloan Kettering Cancer Center (MSK) yielded unprecedented results—remission for every single participant. While it was a small trial with 14 participants, the results are extremely encouraging. According to MSK...
by Bill Malloy | Aug 15, 2023 | Cancer, Health, Technology
A study published recently in the scientific journal Nature Communications analyzed how a new technology could be used to detect lung cancer at the cellular level. The researchers believe this technology could allow physicians to diagnose lung cancer earlier, opening...
by Bill Malloy | Aug 10, 2023 | Cancer, Health
A recent animal study by cancer researchers at Washington State University led to a discovery related to a specific type of white blood cell. The researchers believe their findings could be used to improve the effectiveness of cancer immunotherapy in patients with...
by Bill Malloy | Jan 25, 2023 | Health
Some oncology experts are heralding the results of a recent study as a scientific breakthrough with the potential to foster new treatments for melanoma. Researchers out of Sanford Burnham Prebys in California demonstrated that inhibiting a key metabolic enzyme...
by Bill Malloy | May 30, 2022 | Health, Medication, Technology
A variety of technological innovations have made modern-day cancer research exciting, as findings of various studies have provided hope for next-generation treatment methods that could save countless lives. Machine learning methods of data analysis are one of many...
by Bill Malloy | May 23, 2022 | Health, Medication, Pharmaceuticals
In November 2021, a cancer treatment agent called Cytalux was approved by the US Food and Drug Administration (FDA). Between 22,000 and 24,000 women are diagnosed with ovarian cancer each year in the United States. Oncologists are hopeful that this new treatment can...
